FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146457461> ?p ?o ?g. }

• W2146457461 endingPage "209" @default.
• W2146457461 startingPage "204" @default.
• W2146457461 abstract "Due to the protracted natural history of the clinical progression of prostate cancer, biochemical recurrence (BCR) is often used to compare treatment modalities. However, BCR definitions and posttreatment prostate-specific antigen kinetics vary considerably among treatments, calling into the question the validity of such comparisons. To analyze prostate cancer–specific mortality (PCSM) according to treatment-specific nomogram-predicted risk of BCR for men treated by radical prostatectomy (RP), external-beam radiation therapy (EBRT), and brachytherapy. A total of 13 803 men who underwent RP, EBRT, or brachytherapy at two US high-volume hospitals between 1995 and 2008. RP, EBRT, and brachytherapy. The 5-yr progression-free probability (5Y-PFP) was calculated for each patient based on the treatment received using a validated treatment-specific nomogram. Fine and Gray competing risk analysis was then used to estimate PCSM by a patient's predicted 5Y-PFP. Multivariable competing risk regression analysis was used to determine the association of treatment with PCSM after adjusting for nomogram-predicted 5Y-PFP. Men receiving EBRT had higher 10-yr PCSM compared with those treated by RP across the range of nomogram-predicted risks of BCR: 5Y-PFP >75%, 3% versus 0.9%; 5Y-PFP 51–75%, 6.8% versus 5.9%; 5Y-PFP 26–50%, 12.2% versus 10.6%; and 5Y-PFP ≤25%, 26.6% versus 21.2%. After adjusting for nomogram-predicted 5Y-PFP, EBRT was associated with a significantly increased PCSM risk compared with RP (hazard ratio: 1.5; 95% confidence interval, 1.1–2.0; p = 0.006). No statistically significant difference in PCSM was observed between patients treated by brachytherapy and RP, although patient selection factors and lack of statistical power limited this analysis. EBRT patients with similar nomogram-predicted 5Y-PFP appear to have a significantly increased risk of PCSM compared with those treated by RP. Comparison of treatments using nomogram-predicted BCR end points may not be valid. Biochemical recurrence (BCR) outcomes after external-beam radiation therapy and radical prostatectomy are associated with different risks of subsequent prostate cancer–specific mortality. Physicians and patients should cautiously interpret BCR end points when comparing treatments to make treatment decisions." @default.
• W2146457461 created "2016-06-24" @default.
• W2146457461 creator A5001069772 @default.
• W2146457461 creator A5001454707 @default.
• W2146457461 creator A5015241404 @default.
• W2146457461 creator A5062476184 @default.
• W2146457461 creator A5070471092 @default.
• W2146457461 creator A5072104844 @default.
• W2146457461 creator A5077333954 @default.
• W2146457461 creator A5089619775 @default.
• W2146457461 date "2015-02-01" @default.
• W2146457461 modified "2023-09-25" @default.
• W2146457461 title "Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer–Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence" @default.
• W2146457461 cites W1963592300 @default.
• W2146457461 cites W1964366541 @default.
• W2146457461 cites W1969753482 @default.
• W2146457461 cites W1973652814 @default.
• W2146457461 cites W1973836296 @default.
• W2146457461 cites W1979048558 @default.
• W2146457461 cites W1993539511 @default.
• W2146457461 cites W1999045406 @default.
• W2146457461 cites W2007508216 @default.
• W2146457461 cites W2014320016 @default.
• W2146457461 cites W2016737800 @default.
• W2146457461 cites W2019656569 @default.
• W2146457461 cites W2071879495 @default.
• W2146457461 cites W2072363606 @default.
• W2146457461 cites W2093867637 @default.
• W2146457461 cites W2100001148 @default.
• W2146457461 cites W2105959001 @default.
• W2146457461 cites W2107251918 @default.
• W2146457461 cites W2108776877 @default.
• W2146457461 cites W2117792530 @default.
• W2146457461 cites W2122769082 @default.
• W2146457461 cites W2134002152 @default.
• W2146457461 cites W2144866895 @default.
• W2146457461 cites W2148050247 @default.
• W2146457461 cites W2148705160 @default.
• W2146457461 cites W2152561234 @default.
• W2146457461 cites W2155987515 @default.
• W2146457461 cites W2156549595 @default.
• W2146457461 cites W2161431290 @default.
• W2146457461 cites W2172038823 @default.
• W2146457461 cites W2905153461 @default.
• W2146457461 cites W4205145397 @default.
• W2146457461 doi "https://doi.org/10.1016/j.eururo.2014.09.017" @default.
• W2146457461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25294696" @default.
• W2146457461 hasPublicationYear "2015" @default.
• W2146457461 type Work @default.
• W2146457461 sameAs 2146457461 @default.
• W2146457461 citedByCount "38" @default.
• W2146457461 countsByYear W21464574612014 @default.
• W2146457461 countsByYear W21464574612015 @default.
• W2146457461 countsByYear W21464574612016 @default.
• W2146457461 countsByYear W21464574612017 @default.
• W2146457461 countsByYear W21464574612018 @default.
• W2146457461 countsByYear W21464574612019 @default.
• W2146457461 countsByYear W21464574612020 @default.
• W2146457461 countsByYear W21464574612021 @default.
• W2146457461 countsByYear W21464574612022 @default.
• W2146457461 countsByYear W21464574612023 @default.
• W2146457461 crossrefType "journal-article" @default.
• W2146457461 hasAuthorship W2146457461A5001069772 @default.
• W2146457461 hasAuthorship W2146457461A5001454707 @default.
• W2146457461 hasAuthorship W2146457461A5015241404 @default.
• W2146457461 hasAuthorship W2146457461A5062476184 @default.
• W2146457461 hasAuthorship W2146457461A5070471092 @default.
• W2146457461 hasAuthorship W2146457461A5072104844 @default.
• W2146457461 hasAuthorship W2146457461A5077333954 @default.
• W2146457461 hasAuthorship W2146457461A5089619775 @default.
• W2146457461 hasConcept C121608353 @default.
• W2146457461 hasConcept C126322002 @default.
• W2146457461 hasConcept C126894567 @default.
• W2146457461 hasConcept C143998085 @default.
• W2146457461 hasConcept C207103383 @default.
• W2146457461 hasConcept C2777008409 @default.
• W2146457461 hasConcept C2777416452 @default.
• W2146457461 hasConcept C2779466945 @default.
• W2146457461 hasConcept C2780192828 @default.
• W2146457461 hasConcept C34626388 @default.
• W2146457461 hasConcept C44249647 @default.
• W2146457461 hasConcept C50382708 @default.
• W2146457461 hasConcept C509974204 @default.
• W2146457461 hasConcept C71924100 @default.
• W2146457461 hasConceptScore W2146457461C121608353 @default.
• W2146457461 hasConceptScore W2146457461C126322002 @default.
• W2146457461 hasConceptScore W2146457461C126894567 @default.
• W2146457461 hasConceptScore W2146457461C143998085 @default.
• W2146457461 hasConceptScore W2146457461C207103383 @default.
• W2146457461 hasConceptScore W2146457461C2777008409 @default.
• W2146457461 hasConceptScore W2146457461C2777416452 @default.
• W2146457461 hasConceptScore W2146457461C2779466945 @default.
• W2146457461 hasConceptScore W2146457461C2780192828 @default.
• W2146457461 hasConceptScore W2146457461C34626388 @default.
• W2146457461 hasConceptScore W2146457461C44249647 @default.
• W2146457461 hasConceptScore W2146457461C50382708 @default.
• W2146457461 hasConceptScore W2146457461C509974204 @default.
• W2146457461 hasConceptScore W2146457461C71924100 @default.

• next